#Open journalism No news is bad news

Your contributions will help us continue to deliver the stories that are important to you

Support The Journal
Dublin: 6°C Thursday 20 January 2022
Advertisement

'Breakthrough' breast cancer test to be made available to public

The genetic test can accurately identify the patients who remain at risk following surgery for breast cancer – determining who would benefit from chemotherapy.

Model wear the breast cancer awareness pink ribbon
Model wear the breast cancer awareness pink ribbon
Image: Hannah Marsh/John Birdsall/Press Association Images

A NEW TEST for breast cancer, which has been hailed as a “breakthrough” by experts, is to be offered to all public patients who require it.

The Oncotype DX genetic test can accurately identify the patients who remain at risk following surgery for breast cancer, thereby determining which patients would benefit from chemotherapy.

It is estimated that the test could benefit as many as 500 women in Ireland each year.

The test was initially deemed too expensive to be made publicly available by the National Centre for Pharmacoeconomics, however doctors argued that it could save money in the long-term as it would reduce the number of people seeking chemotherapy.

RTÉ reports that the test will be made available to public patients from this week.

Read: ‘Breakthrough’ cancer test will not be offered to public patients>

About the author:

Read next:

COMMENTS (2)